At this stage it is also likely that the phenotype of M2 macrophages is additionally controlled by CD4+ T helper type 2 (Th2) cells that express IL-4 and IL-13, and counteract the Th1 cell responses, as observed in other cancers (16, 67). Here, IL13 is linked to cancer.